The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development
Abstract
We previously showed that mice with a null mutation in syndecan-1 (Sdc1; CD138) were resistant to Wnt1-induced mammary tumor initiation. The absence of Sdc1 inhibited the increase in the mammary stem cell fraction that is characteristic of preneoplasia in this model. As the tumor precursor cells are recruited from the stem/progenitor cell compartment, tumor development was also inhibited (Liu et al., 2004; PNAS 101, 4158). Although Sdc1-/- mice are grossly normal, they are systemically smaller, suggesting that developmental abnormalities may extend further than their mammary glands. We have therefore evaluated the multi-organ response of Sdc1-/- mice to carcinogen-induced tumor development (7,12-dimethylbenz[a]anthracene, DMBA), and find these mice to be resistant to tumorigenesis in all the predominant carcinogen-susceptible lineages. Thus, Sdc1-/- mice administered DMBA during juvenile development are resistant not only to epithelial tumors, including liver (60-80%) and lung tumors (C57BL6 mice, 60-80%), but also to lymphoma (over 70%, depending upon strain and carcinogen dose). We demonstrate that CD138 is expressed (heterogeneously) in the hematopoietic stem cell fraction (and not only in pre-B and plasma cells), and that tumors arise in both myeloid and lymphoid lineages. Furthermore, carcinogen-induced mammary tumors are bilineal, implying a bipotent precursor cell. Both observations imply that the DMBA-induced tumor precursor cells are drawn from the stem/progenitor fr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, SDC1 is localized to the cell surface and is dispensable for normal tissue homeostasis.33”
From Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers (2025) · cites this paper as [33]
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“Tumor stem cells (observed in breast, neural and hematopoietic tumors; (Al-Hajj et al., 2003; Singh et al., 2003, 2004; Huntly and Gilliland, 2005) possess features in common with normal stem cells, although there is no direct proof of their recruitment from somatic stem cell compartments, nor are…”
BackgroundIdentification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433 · cited 1×
“Tumor stem cells (observed in breast, neural and hematopoietic tumors; (Al-Hajj et al., 2003; Singh et al., 2003, 2004; Huntly and Gilliland, 2005) possess features in common with normal stem cells, although there is no direct proof of their recruitment from somatic stem cell compartments, nor are…”
BackgroundFunctions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688 · cited 3×
“Its function in vitro appears to be dominated by the heparan sulfate side chains, which participate in growth factor signaling by promoting ligand/receptor complex formation (Bernfield et al., 1999; Whitelock and Iozzo, 2005).”
BackgroundMorrison, S. J., & Weissman, I. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90037-x · Cited by 1,115 · cited 2×
“1lo) (Morrison and Weissman, 1994) do not have self-renewal capacity and are similar to the ST-HSC/MPP population.”
BackgroundTaylor, K. R., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4682rev · Cited by 639 · cited 1×
“…during development, Sdc1 / mice are viable and fertile, although their pathologic responses are affected, including those involved in skin wound healing, microbial pathogenesis in the lung and leukocyte adhesion (Park et al., 2001; Gotte et al., 2002; Stepp et al., 2002; Taylor and Gallo, 2006).”
BackgroundLi, Y., Welm, B., Podsypanina, K., Huang, S., Chamorro, M., Zhang, X., Rowlands, T., Egeblad, M., Cowin, P., Werb, Z., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136825100 · Cited by 521 · cited 1×
“In this case, the tumor precursor cell is recruited from these stem/progenitor cells (Li et al., 2003), and in Sdc1 / mice, subsequent tumorigenesis is inhibited.”
BackgroundCardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203277 · Cited by 489 · cited 1×
“Samples were paraformaldehyde-fixed and paraffin-embedded for histopathological evaluation (Cardiff et al., 2000).”
MethodLeukaemia stem cells and the evolution of cancer-stem-cell research
Huntly, B. J. P., & Gilliland, D. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1592 · Cited by 483 · cited 1×
“Tumor stem cells (observed in breast, neural and hematopoietic tumors; (Al-Hajj et al., 2003; Singh et al., 2003, 2004; Huntly and Gilliland, 2005) possess features in common with normal stem cells, although there is no direct proof of their recruitment from somatic stem cell compartments, nor are…”
BackgroundHeparan Sulfate: A Complex Polymer Charged with Biological Activity
Whitelock, J. M., & Iozzo, R. V. (2005) · Chemical Reviews · doi:10.1021/cr010213m · Cited by 410 · cited 2×
“Its function in vitro appears to be dominated by the heparan sulfate side chains, which participate in growth factor signaling by promoting ligand/receptor complex formation (Bernfield et al., 1999; Whitelock and Iozzo, 2005).”
BackgroundClassification of Proliferative Pulmonary Lesions of the Mouse
Nikitin, A. Y., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3376 · Cited by 334 · cited 2×
“(Hy, by the criteria of Nikitin et al. (2004); examples shown below),”
BackgroundSyndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
Alexander, C. M., Reichsman, F., Hinkes, M. T., Lincecum, J., Becker, K. A., Cumberledge, S., & Bernfield, M. (2000) · Nature Genetics · doi:10.1038/77108 · Cited by 305 · cited 2×
“This result was unexpected given that a high fraction of MMTV integration sites activate Wnt loci to induce tumors (van Leeuwen and Nusse, 1995), and we know that Sdc1 promotes Wnt-initiated tumorigenesis (Alexander et al., 2000).”
MethodSelf-citationLiu, B. Y., McDermott, S. P., Khwaja, S. S., & Alexander, C. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400699101 · Cited by 293 · cited 3×
“Previously, we have shown that the absence of Sdc1 inhibits the pathogenic accumulation of mammary stem cells in Wnt-induced glands (Liu et al., 2004).”
BackgroundSelf-citationSkripitz, R., Andreassen, T. T., & Aspenberg, P. (2000) · Cited by 287
Differential Expression of Novel Potential Regulators in Hematopoietic Stem Cells
Forsberg, E. C., Prohaska, S. S., Katzman, S., Heffner, G. C., Stuart, J. M., & Weissman, I. L. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010028 · Cited by 285 · cited 2×
“This is consistent with the Sdc1 expression pattern detected by transcriptional profiling of similarly purified fractions (Forsberg et al., 2005), and suggests that Sdc1 expression is induced upon maturation and differentiation of LT-HSCs.”
BackgroundResultExploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence
Park, P. W., Pier, G. B., Hinkes, M. T., & Bernfield, M. (2001) · Nature · doi:10.1038/35075100 · Cited by 243 · cited 2×
“Despite its abundant expression and early expression during development, Sdc1 / mice are viable and fertile, although their pathologic responses are affected, including those involved in skin wound healing, microbial pathogenesis in the lung and leukocyte adhesion (Park et al., 2001; Gotte et al., 2002; Stepp et al.,…”
BackgroundDefects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse
Stepp, M. A., Gibson, H. E., Gala, P. H., Iglesia, D. D. S., Pajoohesh-Ganji, A., Pal-Ghosh, S., Brown, M., Aquino, C., Schwartz, A. M., Goldberger, O., et al. (2002) · Journal of Cell Science · doi:10.1242/jcs.00128 · Cited by 230 · cited 3×
“Despite its abundant expression and early expression during development, Sdc1 / mice are viable and fertile, although their pathologic responses are affected, including those involved in skin wound healing, microbial pathogenesis in the lung and leukocyte adhesion (Park et al., 2001; Gotte et al., 2002; Stepp et al.,…”
BackgroundMethodBunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., & Bradfield, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209594200 · Cited by 215
Tumor Formation Dependent on Proteoglycan Biosynthesis
Esko, J. D., Rostand, K. S., & Weinke, J. L. (1988) · Science · doi:10.1126/science.3137658 · Cited by 215 · cited 1×
“Sdc1 may modify inflammatory responses to tumor cell growth (Esko et al., 1988).”
BackgroundSyndecans-1 and -4 Are Induced During Wound Repair of Neonatal but Not Fetal Skin
Gallo, R., Kim, C., Kokenyesi, R., Scott Adzick, N., & Bernfield, M. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12365571 · Cited by 175 · cited 1×
“Sdc1 has been shown to be induced in stromal cell compartments during embryogenesis, mammary development and wound healing (Sutherland et al., 1991; Gallo et al., 1996; Maeda et al., 2004).”
BackgroundHeparan Sulfate Core Proteins in Cell-Cell Signaling
Kramer, K. L., & Yost, H. J. (2003) · Annual Review of Genetics · doi:10.1146/annurev.genet.37.061103.090226 · Cited by 165 · cited 2×
“When there is compensatory GAG-ylation of other proteins, it becomes difficult to conclusively ascribe the effects of a null mutation to a specific molecular function (Kramer and Yost, 2003).”
BackgroundMaeda, T., Alexander, C. M., & Friedl, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2439 · Cited by 141 · cited 2×
“Sdc1 has been shown to be induced in stromal cell compartments during embryogenesis, mammary development and wound healing (Sutherland et al., 1991; Gallo et al., 1996; Maeda et al., 2004).”
BackgroundSelf-citationMaeda, T., Desouky, J., & Friedl, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209168 · Cited by 135 · cited 1×
“In keeping with this ‘reactive’ pattern, Sdc1 is frequently expressed by stromal cells associated with breast carcinomas, and promotes growth of MDA-MB-231 breast cancer cells, when overexpressed in stromal cells and co-injected (Maeda et al., 2006).”
BackgroundRole of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature.
Götte, M., Joussen, A. M., Klein, C., André, P., Wagner, D. D., Hinkes, M. T., Kirchhof, B., Adamis, A. P., & Bernfield, M. R. (2002) · PubMed · Cited by 132
Frizzled 9 knock-out mice have abnormal B-cell development
Ranheim, E. A., Kwan, H. C. K., Reya, T., Wang, Y.-K., Weissman, I. L., & Francke, U. (2004) · Blood · doi:10.1182/blood-2004-06-2334 · Cited by 132 · cited 1×
“1; gift of Irving Weissman; Morrison and Weissman, 1994) as described (Ranheim et al., 2005).”
BackgroundSelf-citationShackleford, G. M., MacArthur, C. A., Kwan, H. C. K., & VARMUS, H. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.740 · Cited by 131 · cited 7×
“Sdc1 / tissues are protected during active growth, but adult Sdc1 / mice show no effect (in response to MMTV infection or DMBA administration).”
InfluentialSutherland, A. E., Sanderson, R. D., Mayes, M., Seibert, M., Calarco, P. G., Damsky, C. H., & Bernfield, M. R. (1991) · Development · doi:10.1242/dev.113.1.339 · Cited by 113
Heidel, S. M., MacWilliams, P. S., Baird, W. M., Dashwood, W. M., Buters, J., Gonzalez, F. J., Larsen, M. C., Czuprynski, C. J., & Jefcoate, C. R. E. (2000) · PubMed · Cited by 105
Identification of Stem Cell Units in the Terminal End Bud and Duct of the Mouse Mammary Gland
Kenney, N. J., Smith, G. H., Lawrence, E., Barrett, J. C., & Salomon, D. S. (2001) · BioMed Research International · doi:10.1155/s1110724301000304 · Cited by 96 · cited 1×
“Mammary end buds lead the extension of the developing ductal tree, and are widely considered to be the source of ductal stem cell activity (Kenney et al., 2001).”
BackgroundShackleford, G. M., & VARMUS, H. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9655 · Cited by 89 · cited 1×
“Four-week-old female BALB/c:Sdc1þ /þ and Sdc1 / (N6) mice were injected intraperitoneally with MMTV-producing EH23 cells (Shackleford and Varmus, 1988).”
MethodExperimental basis for the prevention of breast cancer
Mehta, R. G. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00100-3 · Cited by 75 · cited 1×
“A synthetic PAH, DMBA (7,12-dimethylbenz[a]anthracene) has been used extensively to induce breast tumors in rodent models, and this model is used as the ‘gold standard’ to evaluate potential therapeutic modalities (Mehta, 2000).”
MethodLiu, B. Y., Kim, Y. C., Leatherberry, V., Cowin, P., & Alexander, C. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207217 · Cited by 57 · cited 3×
“We have previously shown that heparan sulfate is conjugated to other core proteins in Sdc1 / mice (Liu et al., 2003), suggesting that this compensatory process could be responsible for the effective rescue of HS-mediated functions.”
BackgroundSelf-citationOncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer
van Leeuwen, F. N., & Nusse, R. (1995) · Seminars in Cancer Biology · doi:10.1006/scbi.1995.0018 · Cited by 51 · cited 1×
“This result was unexpected given that a high fraction of MMTV integration sites activate Wnt loci to induce tumors (van Leeuwen and Nusse, 1995), and we know that Sdc1 promotes Wnt-initiated tumorigenesis (Alexander et al., 2000).”
ResultWalters, M. A. (1966) · British Journal of Cancer · doi:10.1038/bjc.1966.17 · Cited by 41 · cited 1×
“This carcinogen also induces tumors in rodents in other organs, when administered during juvenile development, principally for lung, liver and the hematopoietic lineages (Walters, 1966; Flaks, 1968; Roe and Walters, 1968; Akamatsu, 1975; Heidel et al., 2000).”
BackgroundFlaks, A. (1968) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(68)90042-x · Cited by 23 · cited 1×
“This carcinogen also induces tumors in rodents in other organs, when administered during juvenile development, principally for lung, liver and the hematopoietic lineages (Walters, 1966; Flaks, 1968; Roe and Walters, 1968; Akamatsu, 1975; Heidel et al., 2000).”
BackgroundMammary stem and progenitor cells: Tumour precursors?
Paguirigan, A. L., Beebe, D. J., Liu, B., & Alexander, C. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.048 · Cited by 18 · cited 1×
“To predict the effect of underactive mammary stem cells upon mammary development, we have simulated organogenesis using a mathematical model (Paguirigan et al., 2006), and showed that the Received 12 April 2006; revised 4 July 2006; accepted 14 July 2006; published online 4 September 2006…”
MethodSelf-citationAkamatsus, Y. (1975) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/55.4.893 · Cited by 12
Sensitivity of newborn mice to carcinogenic agents
Roe, F. J. C., & Walters, M. A. (1968) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(68)90302-7 · Cited by 5 · cited 1×
“This carcinogen also induces tumors in rodents in other organs, when administered during juvenile development, principally for lung, liver and the hematopoietic lineages (Walters, 1966; Flaks, 1968; Roe and Walters, 1968; Akamatsu, 1975; Heidel et al., 2000).”
Background(2003) · PubMed
Cited by
Sarrazin, S., Lamanna, W. C., & Esko, J. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004952 · Cited by 1,516
“2009); juvenile mice resistant to carcinogen-induced tumorigenesis (McDermott et al. 2007); increased basal protein leakage and more susceptible to protein loss induced by combinations of IFN-g, TNF-a, and increased venous pressure (Bode et al.”
BackgroundAligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., Friedl, A., & Keely, P. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.076 · Cited by 1,285
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Iozzo, R. V., & Sanderson, R. D. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01236.x · Cited by 569
“Further studies probing the mechanism of syndecan-1 activity in tumorigenesis indicate that the proteoglycan may be required for the activation of tumour precursor cells that arise within the stem/progenitor cell compartment [121, 122].”
BackgroundIbrahim, S. A., Gadalla, R., El-Ghonaimy, E. A., Samir, O., Mohamed, H. T., Hassan, H., Greve, B., El-Shinawi, M., Mohamed, M. M., & Götte, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0621-z · Cited by 270
“[16], and in Syndecan-1- knockout mice [29, 30].”
The signaling mechanisms of syndecan heparan sulfate proteoglycans
Lambaerts, K., Wilcox-Adelman, S. A., & Zimmermann, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.05.002 · Cited by 199
“(2) DNA uptake relies on HSPGs, lipid rafts and macropinocytosis but is independent of clathrin, dynamin and caveolin-1 [52].”
Metadata
- Authors
- McDermott, S. P., Ranheim, E. A., Leatherberry, V. S., Khwaja, S. S., Klos, K. S., & Alexander, C. M.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Alexander, C M
- Venue
- Oncogene
- Published
- 2006-09-04
- Volume
- 26
- Issue
- 10
- Pages
- 1407-1416
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2076413581
- Cited by
- 61
- References
- 38
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 8
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (T32-CA09135, T32CA009135, R01CA090877, CA 90877)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- syndecan-1, DMBA-induced carcinogenesis, tumor resistance, mammary tumors, liver tumors, lung cancer, lymphoma, hematopoietic stem cells, stem/progenitor cells, juvenile development
- MeSH terms
- Age Factors, Animals, Carcinogens, Female, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, Experimental, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Body Size, Mice, Syndecan-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.